Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, doctors and other qualified prescribers in the UK can prescribe weight loss injections — but only after a clinical assessment confirms you meet the eligibility criteria. Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both licensed weight loss injections for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. They are prescription-only medicines, which means a prescriber decides suitability after reviewing your health history, weight, and any other medicines you take. No legitimate route bypasses that step.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The question our prescribers hear regularly is some version of: "I clearly need help, why can't a doctor just prescribe this?" The honest answer is that these medicines interact with your wider health picture in ways that matter clinically. A prescriber needs to know about your kidney function, your history with pancreatitis or gallbladder disease, whether you take oral contraceptives (tirzepatide can reduce their absorption in the first weeks of each dose increase), and what other medicines you use daily. That review exists to protect you, not to obstruct you.
The NHS patient guide to tirzepatide sets out the contraindications and cautions in plain language, it is worth reading before any consultation. Medullary thyroid carcinoma, a personal or family history of MEN2, and certain gastrointestinal conditions all require careful discussion. None of this means most people are ineligible. It means the prescriber needs the full picture before signing.
Side effects are also part of the conversation. Nausea, loose stools, constipation, and indigestion are the most common, typically settling after the first weeks at a new dose. More seriously, the MHRA highlighted acute pancreatitis as a known (if infrequent) risk in a January 2026 Drug Safety Update; severe stomach pain spreading to the back warrants urgent medical attention. A prescriber who knows your history is far better placed to spot early warning signs than one who does not.
Some do, but availability is tightly restricted. NICE's technology appraisal for tirzepatide (TA1026) set out a phased NHS rollout: from June 2025, adults with a BMI of 40 or above and four or more specific weight-related conditions became eligible; from June 2026, the threshold dropped to BMI 35–39.9 with four or more of those conditions. Further phases follow in 2027. Every NHS patient must also take part in structured diet and activity support alongside the medicine.
For semaglutide (Wegovy), NICE TA875 restricts NHS prescribing to specialist weight management services and caps treatment at two years. Waiting lists for those services are often long. GP participation in the new tirzepatide contract is optional, so provision varies considerably by practice and area.
The practical reality for many people: even if they would qualify under NICE criteria, their GP surgery is not yet prescribing, or the waiting time is measured in months. That gap is one reason regulated private services exist. If you are wondering whether your GP will prescribe weight loss injections, our dedicated page covers the factors that influence that decision, from local commissioning to individual practice policies. If you want to understand the NHS route in more detail, our page on weight loss injections on the NHS covers the current phases and eligibility thresholds.
Yes, provided they are a GPhC-registered Independent Prescriber or a registered doctor, and the pharmacy is registered with the GPhC. The prescription must follow a genuine clinical assessment, not a tick-box form. At nume, every consultation is read and decided by a named GPhC-registered Independent Prescriber, the same day. Your identity is verified by photo ID, and your weight is confirmed on a live video call. The consultation is free, and if treatment is clinically appropriate, your medicine is dispensed from our GPhC-registered pharmacy and arrives the next working day with DPD, in plain packaging.
You can verify any online pharmacy's registration on the GPhC register before you hand over any personal or payment information. If a seller is not on that register, that alone is reason to stop. The MHRA has warned repeatedly about fake pens sold through social media and unregulated websites, in October 2025, the first illicit UK site producing counterfeit tirzepatide pens was raided. The risk with unverified sellers is not just a wasted purchase; fake pens have contained insulin.
For more on what doctor-prescribed treatment looks like in practice, our guide to doctor-prescribed weight loss injections covers the process from first consultation to ongoing dose review. You can also read about whether doctors can prescribe weight loss injections and what that process involves clinically, including what the new NHS contract means for primary care. You can also read about whether a GP can prescribe these medicines specifically, including what the new NHS contract means for primary care.
It is simpler than most people expect, and slower than the dodgy sellers want you to believe. At a regulated service, you complete a health questionnaire covering your BMI, medical history, current medicines, and reasons for seeking treatment. A prescriber (a real clinician, not a scoring algorithm) reads your answers and makes a clinical decision. If approved, a prescription is issued and the medicine is dispensed that same day (for orders placed before 12pm, Monday to Friday).
Repeat orders are not automatic. Before each new supply, the same clinical review applies: weight evidence, any new symptoms, whether the current dose is working. That ongoing oversight is part of what a legitimate prescription service provides, not an inconvenience bolted on top. The pen lives in your fridge (the same door as the milk) and you inject once a week on a day that suits your routine.
If you would like to understand the full treatment landscape before deciding, our weight management overview sets out how these medicines sit alongside lifestyle changes. When you are ready to talk to a prescriber, you can check your eligibility with a free consultation, no referral needed, no GP letter required, just your health details and a clinician who will give you a straight answer.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.